Ultragenyx Pharmaceutical Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Ultragenyx Pharmaceutical Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2013 to Q2 2024.
  • Ultragenyx Pharmaceutical Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $39.4M, a 13.6% increase year-over-year.
  • Ultragenyx Pharmaceutical Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $145M, a 10% increase year-over-year.
  • Ultragenyx Pharmaceutical Inc. annual Share-based Payment Arrangement, Expense for 2023 was $135M, a 3.72% increase from 2022.
  • Ultragenyx Pharmaceutical Inc. annual Share-based Payment Arrangement, Expense for 2022 was $130M, a 24.2% increase from 2021.
  • Ultragenyx Pharmaceutical Inc. annual Share-based Payment Arrangement, Expense for 2021 was $105M, a 22.4% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $145M $39.4M +$4.71M +13.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $140M $36.9M +$5M +15.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $135M $33.7M +$4.39M +15% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 $131M $34.9M -$884K -2.47% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $132M $34.7M -$1.21M -3.38% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 $133M $31.9M +$2.55M +8.68% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $130M $29.4M +$2.81M +10.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 $128M $35.8M +$8.77M +32.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $119M $35.9M +$8.72M +32.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $110M $29.4M +$5.09M +20.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $105M $26.5M +$3.74M +16.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 $101M $27M +$6.65M +32.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $94.6M $27.1M +$4.73M +21.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-29
Q1 2021 $89.9M $24.3M +$4.13M +20.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $85.7M $22.8M +$3.15M +16% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-17
Q3 2020 $82.6M $20.3M +$434K +2.18% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $82.1M $22.4M +$202K +0.91% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $81.9M $20.2M -$49K -0.24% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $82M $19.7M -$1.42M -6.74% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-15
Q3 2019 $83.4M $19.9M -$760K -3.68% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-27
Q2 2019 $84.2M $22.2M +$2.64M +13.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $81.5M $20.2M +$1.42M +7.58% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $80.1M $21.1M +$1.54M +7.88% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-12
Q3 2018 $78.6M $20.7M +$3.49M +20.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $75.1M $19.6M +$2.77M +16.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 $72.3M $18.8M +$4.3M +29.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $68M $19.5M +$6M +44.3% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-14
Q3 2017 $62M $17.2M +$3.49M +25.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $58.5M $16.8M +$5.93M +54.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $52.6M $14.5M +$4.28M +41.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $48.3M $13.5M +$4.05M +42.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-20
Q3 2016 $44.3M $13.7M +$5.8M +73.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 $38.5M $10.9M +$5.77M +113% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-28
Q1 2016 $32.7M $10.2M +$7.81M +324% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $24.9M $9.49M +$7.49M +374% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-21
Q3 2015 $17.4M $7.9M +$6.24M +378% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $11.2M $5.09M +$4.15M +438% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $7.01M $2.41M +$1.61M +203% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $5.39M $2M +$1.79M +853% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-17
Q3 2014 $3.6M $1.65M +$1.58M +2227% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 $2.02M $946K +$761K +411% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $1.26M $795K +$604K +316% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q4 2013 $657K $210K Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 $71K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $185K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 $191K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.